• AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer

    المصدر: NASDAQ Stocks / 04 يوليو 2025 06:53:04   America/Los_Angeles

    AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio. https://www.nasdaq.com/articles/azns-imfinzi-wins-eu-nod-muscle-invasive-bladder-cancer
شارك على،